Drug Safety : A Side-by-Side Comparison of Bills in the 110th Congress.
Examines increasing concerns regarding the ability of the FDA to ensure that drugs sold in the U.S. are safe and effective, and discusses 2006 report of the Institute of Medicine (IOM) on drug safety. Provides side-by-side comparison of IOM recommendations, FDA plans to address problems, and legisla...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
2007.
|
| Series: | U.S. Congressional Research.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Examines increasing concerns regarding the ability of the FDA to ensure that drugs sold in the U.S. are safe and effective, and discusses 2006 report of the Institute of Medicine (IOM) on drug safety. Provides side-by-side comparison of IOM recommendations, FDA plans to address problems, and legislation introduced in the 110th Congress concerning drug safety and the role of the FDA in protecting public health. |
|---|---|
| Item Description: | Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource. |
| Physical Description: | 1 online resource. |